Fight The Fakes

Speak up about fake medicines.

Medicines for Malaria Venture (MMV)

Medicines for Malaria Venture (MMV)

Address:
PO Box 1826
20, rte de Pré-Bois
1215 Geneva 15
Switzerland

Tel:
+41 22 799 40 60

Fax:
+41 22 799 40 61

Email:
banerjij@mmv.org

Website: http://www.mmv.org

Twitter: http://www.twitter.com/MedsforMalaria

Facebook: http://www.facebook.com/medicinesformalaria

YouTube: http://www.youtube.com/user/MMVMeds4Malaria

Medicines for Malaria Venture (MMV)  is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs.

 
Since its foundation in 1999, MMV has developed and brought to registration four new medicines with its partners: Pyramax®, (pyronaridine-artesunate) co-developed with Shin Poong; Eurartesim® (dihydroartemisinin-piperaquine) with Sigma-Tau; Guilin’s artesunate injection for the treatment of severe malaria, Artesun®; and Coartem® Dispersible (artemether-lumefantrine), a child-friendly formulation developed with Novartis. Since 2009, over 200 million courses of Coartem Dispersible treatment have been supplied to 50 malaria-endemic countries; and since prequalification in 2010, an estimated 12 million vials of artesunate injection have been delivered, saving 80,000-90,000 additional lives.

 
Managing the largest portfolio of antimalarial R&D projects ever assembled, of over 65 projects, MMV has seven new drugs in clinical development addressing unmet medical needs in malaria, including medicines for children, pregnant women and relapsing malaria, and drugs that could support the elimination/eradication agenda. MMV’s success in research and access & product management comes from its extensive partnership network of over 300 pharmaceutical, academic and endemic-country partners in 50 countries.

 

 

MMV’s vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease.

Primary Contacts

Placeholder

Interested in becoming a partner of Fight the Fakes?

If you are part of an organization that is deeply concerned and active in combatting the production and distribution of fake medicines, please do get in touch via our contact page with details about your work.

Become a Partner